Éric Levy

1.6k citations
38 papers · 1.2k · h-index 18

Impact in

    • Chemotherapy-related skin toxicity
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Treatment and Pharmacology
    • Viral-associated cancers and disorders

Papers in

    • Cancer Immunotherapy and Biomarkers 7
    • Viral-associated cancers and disorders 3
    • Cancer Genomics and Diagnostics 5
    • Breast Cancer Treatment Studies 4

Éric Levy

34 papers receiving 1.1k citations

Peers

Éric Levy
Comparison fields: 5 of 97
  • Dermatology 181
  • Oncology 442
  • Immunology 269
  • Cancer Research 121
  • Pathology and Forensic Medicine 78
Replace Naotaka Shibagaki with:
Naotaka Shibagaki Japan
Ryan Cooper United States
Chiara Menin Italy
David H. Dreyfus United States
Lorena Maestre Spain
Evelyn Nguyen United States
Yasuhiko Munakata Japan
PC Nowell United States
Yoshitaka Imaizumi Japan
Éric Levy relative to Naotaka Shibagaki Japan Naotaka Shibagaki's profile →
Citations per field
00.5×
Naotaka Shibagaki · 1×
Citations per year

Countries citing papers authored by Éric Levy

Since Specialization
Citations

This map shows the geographic impact of Éric Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Levy more than expected).

Fields of papers citing papers by Éric Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Levy. The network helps show where Éric Levy may publish in the future.

Co-authors

The 25 scholars most cited alongside Éric Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Éric Levy Line = papers co-authored together Éric Levy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008170
2 2005136
3 2017109
4 2016100
5 201690
6 200386
7 200877
8 199873
9 199451
10 202137
11 200929
12 200528
13 201624
14 202121
15 199921
16 201418
17 202218
18 201317
19 201714
20 200710

About Éric Levy

Éric Levy is a scholar working on Oncology, Cancer Research, Immunology, Molecular Biology and Surgery, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers), Cancer Genomics and Diagnostics (5 papers), Breast Cancer Treatment Studies (4 papers), vaccines and immunoinformatics approaches (4 papers), Viral-associated cancers and disorders (3 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Dermatology (181 citations), Oncology (442 citations), Immunology (269 citations), Cancer Research (121 citations) and Pathology and Forensic Medicine (78 citations). Éric Levy has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Jean‐Marie Andrieu, Stéphane Oudard, Eugéniu Banu, J.P. Le Bourgeois, Elias Haddad, Pascal Piedbois, Éric Tartour, H. Frikha, Helene Thygesen and Krishna B. Clough. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Radiotherapy and Oncology, Bioinformatics and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact